In animals, the double-stranded RNA-specific endonuclease Dicer produces two classes of functionally distinct, tiny RNAs: microRNAs (miRNAs) and small interfering RNAs (siRNAs). miRNAs regulate mRNA translation, whereas siRNAs direct RNA destruction via the RNA interference (RNAi) pathway. Here we show that, in human cell extracts, the miRNA let-7 naturally enters the RNAi pathway, suggesting that only the degree of complementarity between a miRNA and its RNA target determines its function. Human let-7 is a component of the miRNP, which we show is an RNAi enzyme complex. Each let-7-containing complex directs multiple rounds of RNA cleavage, explaining the remarkable efficiency of the RNAi pathway in human cells.
let-7 siRNA duplex with Drosophila embryo lysate in an in vitro RNAi reaction containing a 5′ 32 P-radiolabled target mRNA. This target RNA contained sequence fully complementary to let-7 as well as the sequence from the 3′ untranslated region of the C. elegans lin-41 mRNA that mediates let-7-directed translational repression (Fig. 1B) (23) . The let-7 siRNA directed cleavage of the target RNA only within the sequence that was fully complementary to let-7 ( Fig. 1C) . Thus, the intrinsic sequence of let-7 does not preclude its functioning in RNAi. No cleavage was observed at any other site, including within the lin-41 sequences. The lin-41 sequence differs from the let-7-complementary sequence at only four of the 19 positions that determine siRNA-specificity (Fig. 1B) . The lin-41 sequence was not refractory to RNAi, since an appropriately complementary siRNA directs its cleavage ( Fig. 1D ) (lin-41 siRNA).
Nor does the structure or sequence of the let-7 precursor preclude entry of let-7 into the RNAi pathway. We added synthetic Drosophila melanogaster pre-let-7 RNA (Fig. 1A) to an in vitro RNAi reaction containing the let-7 complementary target RNA. Again, the target RNA was cleaved within the let-7 complementary sequences, but not at any other site (Fig. 1C) . Although pre-let-7 RNA promoted a lower level of RNAi than a let-7 siRNA duplex, it was surprising that RNAi occurred at all, since Dicer cleavage of pre-let-7 generates single-stranded let-7 in vivo and in vitro (3, 22, 7) . It is not known how Dicer produces single-stranded miRNAs but double-stranded siRNAs. One model is that Dicer initially generates an siRNA-like, double-stranded intermediate whose non-miRNA strand is then selectively destroyed. In this model, Dicer would produce the "pre-let-7 siRNA" duplex shown in Fig. 1A . In an in vitro RNAi reaction, this siRNA duplex produced approximately the same amount of target cleavage as pre-let-7 itself (Fig. 1C) . Only a small fraction (∼5%) of the input pre-let-7 RNA (100 nM) is converted to mature let-7 in vitro (3). Thus, when produced from pre-let-7, ∼5 nM mature let-7 entered the RNAi pathway as efficiently 100 nM of the pre-let-7 siRNA duplex, suggesting that production by Dicer cleavage enhances entry of let-7 into the pathway. Dicer action may therefore be coupled to RISC formation, consistent with the interaction of Dicer with the RISC components Ago-2 in Drosophila (31) and Rde-1 in C. elegans (24) .
These experiments suggest that the degree of complementarity between a miRNA and its target RNA is the sole determinant of its function, since single-stranded let-7 can clearly act as an siRNA in vitro. Nonetheless, let-7 might be precluded from entering the RNAi pathway in vivo. We therefore tested if the endogenous let-7 produced by cultured human HeLa cells (3) enters the RNAi pathway.
We tested both HeLa cytoplasmic (S100) and nuclear extracts for their ability to direct cleavage of the let-7-complementary RNA target (Fig. 1B) (25) . In Drosophila embryo lysate, which contains no let-7, this target RNA is cleaved at the let-7-complementary site only upon addition of exogenous let-7 siRNA duplex. In contrast, HeLa cytoplasmic S100-but not nuclear-extract ( Fig. 2A ) directed target RNA cleavage within the let-7-complementary sequences, in the absence of any exogenous siRNA. Target cleavage in HeLa S100 occurred between nucleotides 541 and 542, exactly the same cleavage site directed by the exogenous let-7 siRNA in Drosophila embryo lysate (Fig. 2B) . No target cleavage occurred within the lin-41 sequences contained in the target RNA. These sequences do not pair with let-7 at position 9 and 10 (Fig. 1B) ; mispairing between an siRNA and its target at these positions blocks RNAi (20) (Dianne Schwarz and PDZ, unpublished). These results suggest that the endogenous let-7 in the HeLa cytoplasmic extract is associated with the RNA-induced silencing complex (RISC), the enzyme complex that mediates endonucleolytic cleavage in the RNAi pathway.
To test directly if let-7 was associated with the RISC, we asked if the cleavage activity co-purified with the protein eIF2C2, a member of the PAZ-and-Piwi domain (PPD) family of proteins. PPD proteins are required for RNAi and PTGS in animals (21, 26, 27) , plants (28, 29) , and fungi (30) . In flies, the PPD protein, Ago-2, is a component of the RISC complex (31) , and in Neurospora (Qde-2) (32) and C. elegans (Rde-1) (24) PPD proteins are associated with siRNAs in multi-protein complexes likely to correspond to the RISC. A human RISC has not yet been characterized, but human eIF2C2 has been is associated with an RNA-protein complex (miRNP) that contains miRNAs and is nearly the same size as the Drosophila RISC (33). The let-7 paralog, miR-98, which differs from let-7 at two positions, was previously shown to be in the miRNP (33) . We immunoprecipitated eIF2C2 from HeLa S100 with either monoclonal (8C7) or polyclonal (411-1) antibodies and tested the immunoprecipitates for their ability to cleave the target RNA at the let-7-complementary sequence ( Fig. 2C) (34) . Both let-7 (Fig. 2D ) and the nuclease activity specific for let-7 complementary target sequences (Fig. 2C ) co-purified with eIF2C2. We therefore refer to this activity as a let-7-programmed RISC.
Next, we tested if other components of the miRNPGemin4 and the putative DEAD-box RNA helicase, Gemin3-were also components of the let-7-programmed RISC complex (33) . Monoclonal antibodies to Gemin3 and Gemin4, but not the Survival of Motor Neurons (SMN) protein, immunoprecipitated let-7-programmed RISC activity (Fig. 2C) . SMN is a component of a Gemin3/Gemin4-containing complex that restructures nuclear RNPs; this complex does not contain eIF2C2 (33) . Consistent with the idea that let-7 was pre-assembled into the miRNP before the HeLa cells were lysed, target cleavage in S100 was not enhanced by addition of exogenous let-7 siRNA (data not shown).
Human Dicer protein has previously been shown to be localized to the cytoplasm (35) . The experiments in Fig. 2 suggest that the rest of the human RNAi pathway is likewise cytoplasmic, since no RISC-associated let-7 was detected in the nuclear extract, nor could the nuclear extract be programmed with a let-7-containing siRNA to direct target cleavage. In contrast, an exogenous siRNA duplex complementary to firefly luciferase sequences successfully programmed the HeLa S100 to cleave the target (D. Schwarz, G.H., and P.D.Z., submitted). Although both the endogenous human let-7 and the exogenous luciferase siRNA triggered target cleavage, the two triggers differ in at least one respect: endogenous human let-7 is single-stranded (7, 11, 19) , whereas the siRNA was double-stranded. Double-stranded siRNAs must be unwound in order to direct RNAi; this unwinding requires ATP (12) . Once unwound, RISCassociated siRNAs can cleave their targets in the absence of high energy cofactors (12) . Since let-7 is single-stranded, target cleavage by HeLa let-7 should not require ATP. To test this hypothesis, we depleted ATP (12) from the HeLa S100, then added the let-7-complementary target RNA. The let-7-programmed RISC cleaved the target in the absence of ATP (Fig. 3A) .
Therefore, as in Drosophila embryo lysates (27) , RNAi in human HeLa cytoplasmic extracts does not require ATP for target cleavage. Accordingly, models for the RNAi pathway that invoke the synthesis of new RNA as a prerequisite for target RNA destruction (36) do not accurately describe the mechanism of RNAi in human cells. New RNA synthesis is thought to be an important step for RNAi in C. elegans and Dictyostelium discoideum, post-transcriptional gene silencing in plants, and quelling in Neurospora crassa (9) . In each of these organisms, a member of a family of RNA-dependent RNA polymerases (RdRPs) is required for RNA silencing. In contrast, no such RdRP is encoded by the current release of either the Drosophila or human genome.
Why then is RNAi so efficient in flies and cultured mammalian cells? The concentration of let-7 in HeLa S100 is ≤900 pM (Figs. 3C and D) (37) , and therefore the concentration of let-7-programmed RISC in our reactions is ≤450 pM. Since the target RNA concentration in these experiments was ≥6 nM and 70% of the target was destroyed in 2 hours ( Fig. 2A) , each let-7-programmed RISC must catalyze the cleavage of ≥10 target molecules. (let-7 produced de novo during the reaction is negligible, because the concentration of pre-let-7 in the HeLa S100 is 10-to-20-fold lower than that of let-7 itself.) Thus, the let-7-programmed RISC is a true enzyme, catalyzing multiple rounds of RNA cleavage. It seems highly likely that all RISC's are multipleturnover enzyme complexes.
Our results suggest that human let-7 is in the enzyme complex that mediates RNAi, yet human cells do not contain mRNAs that could function as let-7 RNAi targets. Perhaps let-7 enters two separate complexes, one for RNAi and one for translational control. Such a model implies that a portion of let-7 enters a complex that serves no function in human cells. More likely is that the recently identified miRNP (33) is the human RISC (10, 31) , and that this one complex carries out both target cleavage in the RNAi pathway and translational control in the miRNA pathway (Fig. 4) . Such a view does not preclude miRNAs or siRNAs from also being associated with smaller complexes that contain only a subset of RISC components, but that are nonetheless capable of target RNA cleavage (12) .
At least one plant miRNA (miR171) is perfectly complementary to a potential regulatory target mRNA, raising the possibility that miRNAs may naturally be used in plants for RNAi-based regulation of gene expression (8, 38) . We anticipate that in plants artificial miRNAs will direct translational control when they do not pair with their mRNA targets at the site of cleavage in the RNAi pathway. Conversely, we predict that in animals, synthetic siRNA duplexes with only partial complementarity to their corresponding mRNA targets will repress translation of the mRNA without triggering RNA degradation. 
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